PSNL

Personalis Inc
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$1.71B
P/E Ratio
—
EPS
$-1.16
Beta
2.36
52W High
$18.89
52W Low
$4.96
50-Day MA
$16.20
200-Day MA
$11.41
Dividend Yield
—
Profit Margin
-153.80%
Forward P/E
—
PEG Ratio
—

About Personalis Inc

Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$69.67M
Gross Profit (TTM)$8.84M
EBITDA$-104.60M
Operating Margin-150.20%
Return on Equity-50.30%
Return on Assets-25.00%
Revenue/Share (TTM)$0.71
Book Value$2.55
Price-to-Book7.93
Price-to-Sales (TTM)24.57
EV/Revenue18.97
EV/EBITDA-0.03
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)30.00%
Shares Outstanding$108.40M
Float$86.37M
% Insiders25.64%
% Institutions64.33%

Historical Volatility

HV 10-Day
12.95%
HV 20-Day
13.38%
HV 30-Day
13.49%
HV 60-Day
41.70%
HV Rank
2.4%

Volatility is currently contracting

Analyst Ratings

Consensus ($15.17 target)
2
Buy
3
Hold

Latest News

PSNL Investigation Reminder: Personalis Shareholders Notified of Investigation into $16.25 per Share Merger – Contact BFA Law

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

GlobeNewsWire11/6/2026Neutral
PSNL Investigation Reminder: Personalis $16.25 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

GlobeNewsWire11/4/2026Neutral
PSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of Shareholders

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.  Personalis is incorporated in Delaware.

PRNewsWire11/3/2026Neutral
PSNL Investigation Reminder: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

GlobeNewsWire10/30/2026Neutral
PSNL Merger Notice: BFA Law Notifies Personalis Shareholders of the Ongoing Investigation into the $16.25 per Share Merger

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. New York, New York--(Newsfile Corp. - October 29, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware.

Newsfile Corp10/29/2026Neutral
PSNL Investor Investigation: Personalis Shareholders Are Alerted to the Pending Investigation into the $16.25 per Share Merger

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.  Personalis is incorporated in Delaware.

PRNewsWire10/27/2026Neutral
$PSNL Merger Investigation: BFA Law Reminds Personalis Shareholders of Its Ongoing Investigation into the $16.25 per Share Merger Deal

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

GlobeNewsWire10/26/2026Neutral
PSNL Investigation News: Personalis, Inc. Investors are Notified of the Pending Investigation into Ongoing Merger – Contact BFA Law if You Hold Shares

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

GlobeNewsWire10/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PSNL and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026